Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Optometry (St. Louis, Mo.)|December 20, 2012
Current status on the development and treatment of myopiaJeffrey Cooper, Erica Schulman, Nadine JamalOptometry and Vision Science : Official Publication of the American Academy of Optometry|October 1, 2013
Maximum atropine dose without clinical signs or symptomsJeffrey Cooper, Nadine Eisenberg, Erica Schulman, et al.Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|April 15, 2024
Effects of vision therapy on near exodeviation in children with convergence insufficiency treated during the convergence insufficiency treatment trialsErica Schulman, Mitchell Scheiman, Marjean T Kulp, et al.JAMA Ophthalmology|June 1, 2023
Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical TrialKarla Zadnik, Erica Schulman, Ian Flitcroft, et al.Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)|April 8, 2026
Negligible Rebound in Myopia Progression Following Cessation of Treatment with 0.01% Atropine for 3 years: Year-4 Results from the CHAMP Phase 3 Clinical TrialKarla Zadnik, Erica Schulman, Ian Flitcroft, et al.Pageof 1